PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Ascorbic Acid (Vitamin C)- FDA 20 Drug Drug Adrenalin (Epinephrine)- FDA 42 2 0.07 -0.93 0.10 0.84
Ascorbic Acid (Vitamin C)- FDA 20 Drug Disease Ulcers 45,142 1 0.00 -0.97 0.05 0.59
Ascorbic Acid (Vitamin C)- FDA 20 Drug Disease Heart Disease 118,291 1 0.00 -0.97 0.05 0.57
Dracorhodin 20 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Dracorhodin 20 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Dracorhodin 20 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Dropropizine 19 Drug Disease Sedation 27,984 1 0.00 -0.97 0.05 0.60
Doxacurium Chloride 19 Drug Disease Depression 220,092 3 0.00 -0.92 0.16 0.58
Doxacurium Chloride 19 Drug Drug Droperidol 1,957 1 0.01 -0.97 0.05 0.67
Doxacurium Chloride 19 Drug Disease Stroke 146,992 2 0.00 -0.95 0.11 0.58
Doxacurium Chloride 19 Drug Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
Doxacurium Chloride 19 Drug Disease Muscle Relaxation 4,706 2 0.01 -0.95 0.11 0.67
Doxacurium Chloride 19 Drug Drug Doxacurium 85 19 0.47 -0.20 1.00 0.91
Complement Decay-Accelerating Factor 19 Target Target CEA 17,022 1 0.00 -0.97 0.05 0.61
Complement Decay-Accelerating Factor 19 Target Disease Cancer 1,053,491 2 0.00 -0.95 0.11 0.54
Complement Decay-Accelerating Factor 19 Target Target Calmodulin 25,240 1 0.00 -0.97 0.05 0.60
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Complement Decay-Accelerating Factor 19 Target Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
Complement Decay-Accelerating Factor 19 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.05 0.62
Complement Decay-Accelerating Factor 19 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.11 0.59
Complement Decay-Accelerating Factor 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Complement Decay-Accelerating Factor 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Complement Decay-Accelerating Factor 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Kaad-Cyclopamine 19 Drug Disease Carcinoma 433,099 7 0.00 -0.79 0.37 0.58
Kaad-Cyclopamine 19 Drug Disease Cancer 1,053,491 13 0.00 -0.56 0.68 0.58
Kaad-Cyclopamine 19 Drug Disease Ovarian Cancer 33,996 1 0.00 -0.97 0.05 0.60
Kaad-Cyclopamine 19 Drug Disease Prostate Cancer 71,064 1 0.00 -0.97 0.05 0.58
Kaad-Cyclopamine 19 Drug Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.05 0.63
Kaad-Cyclopamine 19 Drug Target ERK1 18,374 1 0.00 -0.97 0.05 0.61
Kaad-Cyclopamine 19 Drug Target EGF 27,487 1 0.00 -0.97 0.05 0.60
Kaad-Cyclopamine 19 Drug Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
Kaad-Cyclopamine 19 Drug Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
Kaad-Cyclopamine 19 Drug Target Activin A 2,048 1 0.01 -0.97 0.05 0.67
Kaad-Cyclopamine 19 Drug Disease Glioblastoma 17,933 2 0.00 -0.95 0.11 0.63
AMAC-1 19 Target Disease Osteoarthritis 36,287 1 0.00 -0.97 0.05 0.60
AMAC-1 19 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
AMAC-1 19 Target Target CCL4 5,638 1 0.00 -0.97 0.05 0.64
AMAC-1 19 Target Target CD14 9,941 1 0.00 -0.97 0.05 0.63
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Target DC-CK1 22 4 0.20 -0.80 0.21 0.90
AMAC-1 19 Target Target Eotaxin 2,457 1 0.00 -0.97 0.05 0.66
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
AMAC-1 19 Target Target CCL2 3,560 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Aralen (Chloroquine)- FDA 19 Drug Disease Infectious Diseases 33,605 1 0.00 -0.97 0.05 0.60